QLS5212 for Participants With Advanced Solid Tumors

Clinical trial NCT07467629 · RECRUITING

Trial details

NCT number: NCT07467629
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Cancer

Start date: 2026-05-11
Primary completion: 2027-11-05
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.